Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 2
2002 2
2004 5
2005 8
2006 8
2007 10
2008 7
2009 6
2010 7
2011 13
2012 17
2013 13
2014 20
2015 16
2016 16
2017 18
2018 22
2019 10
2020 14
2021 17
2022 6
2023 5
2024 2
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

225 results

Results by year

Filters applied: . Clear all
Page 1
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
Kunzmann V, Siveke JT, Algül H, Goekkurt E, Siegler G, Martens U, Waldschmidt D, Pelzer U, Fuchs M, Kullmann F, Boeck S, Ettrich TJ, Held S, Keller R, Klein I, Germer CT, Stein H, Friess H, Bahra M, Jakobs R, Hartlapp I, Heinemann V; German Pancreatic Cancer Working Group (AIO-PAK) and NEOLAP investigators. Kunzmann V, et al. Among authors: bahra m. Lancet Gastroenterol Hepatol. 2021 Feb;6(2):128-138. doi: 10.1016/S2468-1253(20)30330-7. Epub 2020 Dec 16. Lancet Gastroenterol Hepatol. 2021. PMID: 33338442 Clinical Trial.
Mucosal-associated invariant T cells contribute to suppression of inflammatory myeloid cells in immune-mediated kidney disease.
Gnirck AC, Philipp MS, Waterhölter A, Wunderlich M, Shaikh N, Adamiak V, Henneken L, Kautz T, Xiong T, Klaus D, Tomczyk P, Al-Bahra MM, Menche D, Walkenhorst M, Lantz O, Willing A, Friese MA, Huber TB, Krebs CF, Panzer U, Kurts C, Turner JE. Gnirck AC, et al. Among authors: al bahra mm. Nat Commun. 2023 Nov 15;14(1):7372. doi: 10.1038/s41467-023-43269-0. Nat Commun. 2023. PMID: 37968302 Free PMC article.
Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression.
Cheung PF, Yang J, Fang R, Borgers A, Krengel K, Stoffel A, Althoff K, Yip CW, Siu EHL, Ng LWC, Lang KS, Cham LB, Engel DR, Soun C, Cima I, Scheffler B, Striefler JK, Sinn M, Bahra M, Pelzer U, Oettle H, Markus P, Smeets EMM, Aarntzen EHJG, Savvatakis K, Liffers ST, Lueong SS, Neander C, Bazarna A, Zhang X, Paschen A, Crawford HC, Chan AWH, Cheung ST, Siveke JT. Cheung PF, et al. Among authors: bahra m. Nat Commun. 2022 Jan 10;13(1):156. doi: 10.1038/s41467-021-27088-9. Nat Commun. 2022. PMID: 35013174 Free PMC article.
[Teaching and Training in Robot-assisted Surgery].
Schmelzle M, Malinka T, Bahra M, Pratschke J. Schmelzle M, et al. Among authors: bahra m. Zentralbl Chir. 2020 Jun;145(3):271-277. doi: 10.1055/a-1156-4357. Epub 2020 Jun 4. Zentralbl Chir. 2020. PMID: 32498108 Review. German.
Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma From Chronic Pancreatitis.
Mahajan UM, Oehrle B, Sirtl S, Alnatsha A, Goni E, Regel I, Beyer G, Vornhülz M, Vielhauer J, Chromik A, Bahra M, Klein F, Uhl W, Fahlbusch T, Distler M, Weitz J, Grützmann R, Pilarsky C, Weiss FU, Adam MG, Neoptolemos JP, Kalthoff H, Rad R, Christiansen N, Bethan B, Kamlage B, Lerch MM, Mayerle J. Mahajan UM, et al. Among authors: bahra m. Gastroenterology. 2022 Nov;163(5):1407-1422. doi: 10.1053/j.gastro.2022.07.047. Epub 2022 Jul 21. Gastroenterology. 2022. PMID: 35870514 Free article.
[Drainages in abdominal surgery: (in)dispensable?].
Globke B, Schmelzle M, Bahra M, Pratschke J, Neudecker J. Globke B, et al. Among authors: bahra m. Chirurg. 2017 May;88(5):395-400. doi: 10.1007/s00104-017-0404-5. Chirurg. 2017. PMID: 28361269 Review. German.
Radiologic resectability assessment in pancreatic cancer.
Denecke T, Grieser C, Neuhaus P, Bahra M. Denecke T, et al. Among authors: bahra m. Rofo. 2014 Jan;186(1):23-9. doi: 10.1055/s-0033-1350190. Epub 2013 Sep 30. Rofo. 2014. PMID: 24081785 Free article. Review.
Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study.
Mahajan UM, Oehrle B, Goni E, Strobel O, Kaiser J, Grützmann R, Werner J, Friess H, Gress TM, Seufferlein TW, Uhl W, Will U, Neoptolemos JP, Wittel UA, Vornhülz M, Sirtl S, Beyer G, Regel I, Boeck S, Heinemann V, Frost F, Steveling A, Völzke H, Petersmann A, Nauck M, Weber E, Kamlage B, Lerch MM, Mayerle J; METAPAC trial investigators. Mahajan UM, et al. Lancet Gastroenterol Hepatol. 2025 Jul;10(7):634-647. doi: 10.1016/S2468-1253(25)00056-1. Epub 2025 May 16. Lancet Gastroenterol Hepatol. 2025. PMID: 40388948 Free article. Clinical Trial.
225 results